Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post-Hoc Analysis of Three Clinical Trials
mediaposted on 2021-01-27, 13:52 authored by Adis journals on behalf of, Pedro L. Gonzalez, Urania Rappo, Veronica Mas Casullo, Karthik Akinapelli, Jennifer S. McGregor, Jennifer Nelson, Michael Nowak, Sailaja Puttagunta, Michael W. Dunne
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.